[1] Jemal A.,
Siegel R.,
Ward E.,
Hao Y.,
Xu J.,
Thun M.J.,
“Cancer statistics”,
2009,
CA Cancer J Clin2009; 59:225-249.
[2] Hricak H.,
“MR imaging and MR spectroscopic imaging in the pre-treatment evaluation of prostate cancer”,
Br J Radiol 2005; 78[Spec No 2]:S103-S111.
[3] A.
Villa,
F.
Chiesa,
I.
Rosenberg,
A.
Tagliafico,
M.
Perinetti,
A.
Del Prato,
“MRI and ultrasound guided prostate biopsy using the fusion imaging technique”,
ePOS ECR 2013,
DOI: 10.1594/ecr2013/C-2333.
[4] Shukla-Dave A.,
Hricak H.,
“Role of MRI in prostate cancer detection”,
NMR Biomed.
2014 Jan;27(1):16-24.
DOI: 10.1002/nbm.2934.
[5] Xia Wu,
Feng Zhang,
Ran Chen,
Weiliang Zheng.
“Recent advances in imaging-guided interventions for prostate cancers”,
Cancer Letters 349 (2014) 114-119.
[6] Peter R Carroll,
Fergus V Coakley and John Kurhanewicz,
“Magnetic Resonance Imaging and Spectroscopy of Prostate Cancer“,
Rev Urol.
2006; 8(Suppl 1): S4–S10.
[7] Chan Kyo Kim,
Byung Kwan Park and Bohyun Kim,
“Diffusion-Weighted MRI at 3 T for the Evaluation of Prostate Cancer“,
American Journal of Roentgenology,
2010; 194: 1461-1469.
[8] Noha Mohamed Abdel Mabouda,
Hytham Haroon Elsaida,
Essam Aly Aboubeihb,
“The role of diffusion – Weighted MRI in evaluation of prostate cancer”,
The Egyptian Journal of Radiology and Nuclear Medicine,
Volume 45,
Issue 1,
March 2014,
Pages 231–236.
[9] Hossein Jadvar,
“FDG PET in Prostate Cancer”,
PET Clin.
Apr 1,
2009; 4(2): 155–161.
[10] Powles T,
Murray I,
Brock C,
Oliver T,
Avril N,
“Molecular positron emission tomography and PET/CT imaging in urological malignancies”,
Eur Urol.
2007; 51:1511–21.
[11] Ryogo Minamimoto,
Michio Senda,
Seishi Jinnouchi,
Takashi Terauchi,
Tomio Inoue,
“Detection of prostate cancer by an FDG-PET cancer screening program: results from a Japanese nationwide survey”,
Article 4,
Volume 2,
Issue 1,
Spring 2014,
Page 19-23.
[12] Wahl R.L.,
“Principles and practice of PET and PET/CT”,
2nd ed.
Philadelphia: Lippincott Williams & Wilkins; 2009.
P.
47–57.
[13] Men S,
Cakar B,
Conkbayir I,
Hekimoglu B,
“Detection of prostatic carcinoma: the role of TRUS,
TRUS guided biopsy,
digital rectal examination,
PSA and PSA density”,
J Exp Clin Cancer Res.
2001 Dec;20(4):473-80.
[14] Eisenberg ML,
Cowan JE,
Carroll PR,
Shinohara K,
“The adjunctive use of power Doppler imaging in the preoperative assessment of prostate cancer”,
BJU Int.
2010 May;105(9):1237-41.
doi: 10.1111/j.1464-410X.2009.08958.x.
[15] D.
Junker,
T.
De Zordo,
M.
Quentin,
M.
Ladurner,
J.
Bektic,
W.
Horniger,
W.
Jaschke and F.
Aigner,
“Real-Time Elastography of the Prostate”,
Biomed Res Int.
2014; 2014: 180804.
Published online May 22,
2014.
doi: 10.1155/2014/180804.
[16] Xie SW,
Li HL,
Du J,
Xia JG,
Guo YF,
Xin M,
Li FH,
“Contrast-enhanced ultrasonography with contrast-tuned imaging technology for the detection of prostate cancer: comparison with conventional ultrasonography”,
BJU Int.
2012 Jun;109(11):1620-6.
doi: 10.1111/j.1464-410X.2011.10577.x.
[17] W.
J.
M.
van de Ven,
S.
Rinsma,
N.
Karssemeijer,
J.
O.
Barentsz,
J.
J.
Fütterer,
H.
Huisman,
“Electro-magnetic tracker-based fusion for image-guided TRUS prostate biopsy”,
ECR 2014,
ePOS C-0213,
DOI: 10.1594/ecr2014/C-0213.
[18] P.
Puech et al.,
“Multiparametric MR-targeted Biopsy with Cognitive and Transrectal US–MR Fusion Guidance versus Systematic Biopsy— Prospective Multicenter Study”,
Radiology.
2013 Aug;268(2):461-9.
doi: 10.1148/radiol.13121501.
[19] L.
Appelbaum,
L.
Solbiati,
J.
Sosna et al,
"Evaluation of an electromagnetic image-fusion navigation system for biopsy of small lesions: assessment of accuracy in an in vivo swine model",
Acad Radiol 2013 Feb;20(2):209-17.